Jan. 27, 2026 — QT Imaging and Olea Medical have announced plans to collaborate. This collaboration enhances QT Imaging’s Cloud SaaS Platform by integrating Olea Medical’s advanced visualization, quantitative analytics and AI-ready imaging technologies to support clinical interpretation, research workflows and quantitative imaging analysis.
The Olea collaboration builds on QT Imaging’s existing cloud infrastructure, to be delivered through InteleShare platform, which provides the enterprise PACS and cloud backbone for QT Imaging’s clinical and research deployments.
Together, these capabilities strengthen QT Imaging’s end-to-end imaging ecosystem, enabling secure cloud-based delivery of QT Imaging Breast Acoustic CT studies with high-performance visualization, advanced quantitative analysis, and multimodality integration.
Under the collaboration:
- QT imaging data will be enabled for relevant clinical interpretation within QT Imaging’s infrastructure, incorporating Olea Medical’s validated visualization and analytics technologies.
- The combined solution supports a scalable multimodality breast imaging approach, integrating mammography, digital breast tomosynthesis (DBT), ultrasound, MR imaging and QT Imaging studies across the breast care pathway.
- Advanced quantitative analytics, segmentation and volumetric analysis, will support improved lesion characterization, diagnostic confidence, and clinical efficiency.
- Secure, network-enabled access enables multi-institutional collaboration, centralized research workflows, and standardized clinical trial support.
The collaboration aligns with QT Imaging’s roadmap to expand adoption of its Breast Acoustic CT™ technology while supporting future AI- and machine learning-driven analytics, delivered through its cloud infrastructure.
As part of the collaboration, QT Imaging will distribute the QT Imaging Olea Vision software, a highly customizable 3D and 4D DICOM viewer with user-defined hanging protocols offering functionalities such as intuitive navigation across DICOM series, advanced 3D data loading and visualization, and image manipulation. The software also includes subtraction tools to support enhanced diagnostic assessment.
“Our collaboration with Olea Medical strengthens the clinical visualization and analytical capabilities of QT Imaging’s cloud platform,” said Dr. Raluca Dinu, Chief Executive Officer of QT Imaging. “Together with the enterprise delivery infrastructure we are putting in place, this collaboration supports our mission to deliver advanced, quantitative breast imaging at scale for both research and clinical care.”
“We are pleased to collaborate with QT Imaging to bring our advanced visualization and quantitative imaging expertise into next-generation breast imaging,” said Dr. Faycal Djeridane, Founder and CEO of Olea Medical. “This collaboration reflects a shared commitment to clinically meaningful innovation, multimodality integration and quantitative imaging.”
For more information, please visit www.olea-medical.com. and www.qtimaging.com.
September 18, 2026 
